article Open AccessTop 1% cited
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
Breast Cancer Research and Treatment · 2014 · Vol. 146(1) · pp. 15–24
Simone Muenst✉(University Hospital of Basel)A. R. Schaerli(University Hospital of Basel)Feng Gao(Washington University in St. Louis)Silvio Däster(University of Basel)Emanuele Trella(University of Basel)Raoul A. Droeser(University Hospital of Basel)Manuele Giuseppe Muraro(University of Basel)Paul Zajac(University of Basel)Rosanna Zanetti(University Hospital of Basel)W.E. Gillanders(Washington University in St. Louis)William P. Weber(University Hospital of Basel)Savas D. Soysal(University of Basel)
Cancer Immunotherapy and BiomarkersCancer Cells and MetastasisHER2/EGFR in Cancer ResearchBreast cancerImmunohistochemistryCancerTissue microarrayMedicineCancer researchOncologyPD-L1Internal medicinePathology
MeSH terms
AdultAgedAged, 80 and overBreast NeoplasmsFemaleHumansImmunohistochemistryMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisGene ExpressionImmunophenotypingTissue Array AnalysisTumor Burden
Funding
- Alvin J. Siteman Cancer Center
- National Cancer Institute
Citations
577
FWCI
25.50
field-weighted impact
References
59
Percentile
100%
vs. same field & year
Citations per year
Cited by
Prognostic and predictive value of PDL1 expression in breast cancer
Oncotarget · 2014 · 496 citations
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Human Pathology · 2015 · 336 citations
T-cell exhaustion in the tumor microenvironment
Cell Death and Disease · 2015 · 1,120 citations
References
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
European Journal of Immunology · 2003 · 625 citations
Cancer immunotherapy: moving beyond current vaccines
Nature Medicine · 2004 · 2,953 citations
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Journal of Clinical Oncology · 2010 · 2,913 citations
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Nature Medicine · 2002 · 4,970 citations
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
Breast Cancer Research and Treatment · 2013 · 342 citations
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Science Translational Medicine · 2012 · 2,123 citations
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
PLoS Medicine · 2010 · 1,150 citations
Molecular portraits of human breast tumours
Nature · 2000 · 16,173 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.